Biostem Technologies, Inc. Starts International Operations in Guadalajara, Mexico

Biostem Technologies, Inc.(OTCPINK:BSEM) entered into an agreement with Dr. Jesus Esparragoza Romano and his team in Guadalajara, Mexico to form the Mexican entity — Bio ST Holdings, S. de R.L. de C.V. which is a wholly owned subsidiary of Biostem Technologies, Inc.
According to the news:

Biostem Technologies, Inc. is also proudly announcing the addition of cardiologist, Dr. Jesus Esparragoza Romano, as its Chief Medical Advisor of Bio ST Holdings, S. de R.L. de C.V. Dr. Esparragoza, M.D. is a Fellow of American College of Cardiology who graduated from the Faculty of Medicine of the University Autónoma de Guadalajara in 1977, and acquired the title of Doctor Surgeon; then, in 1979 studied an intensive course of medicine at the Oakland University in Rochester, Michigan. He went on to complete his studies of Internal Medicine specializing in Cardiology at the Centro Médico de Occidente Hospital at Guadalajara, Jalisco where in conjunction with several doctors, performed the first heart transplant. Dr. Esparragoza also consults with the adult services program at the Heart Institute for Cardiology in Houston Texas and is a certified member of interventional Cardiology by SOCIME (Society of Interventional Cardiology of México). He has been working with adult stem cells for over 8 years now.

CEO Jason Matuszewski stated:

We have evaluated several different physicians and facilities. Based on quality of care and medical staff/personnel, we believe that Dr. Esparragoza, who works at the San Javier Hospital, has exceeded our expectations for medical care and would be an asset to our team. We look forward to working with him in the stem cell sector.

Click here to view the full press release.